Table 3 Poor prognosis in three groups stratified by serum calcium trajectories
Outcomes | Total (n = 383) | High group (n = 85) | Medium group (n = 259) | Continuous low group (n = 39) | P -value |
|---|---|---|---|---|---|
ICU stay time(day), median (IQR) | 7(4, 11) | 6(4, 12) | 7(4, 11) | 6(4, 12) | 0.090a |
Hospital stays(day), median (IQR) | 22(17, 31) | 21(16, 30) | 23(17, 34) | 23(16, 32) | 0.077a |
Death in hospital, n, (%) | 66(17.2) | 10(11.8) | 44(17.0) | 12(30.8) | 0.033 |
In-hospital Complications | |||||
MACCEs, n, (%) | 32(8.4) | 6 (7.1) | 17(6.6) | 9 (17.9) | 0.002 |
Pulmonary complications, n, (%) | 138 (36.0) | 27(31.8) | 94(36.3) | 17(43.6) | 0.439 |
Gastrointestinal bleeding, n, (%) | 40 (10.5) | 9(10.6) | 25(9.7) | 6 (15.4) | 0.556 |
Acute kidney injury, n, (%) | 174(45.4) | 35(41.2) | 114(44.0) | 25(64.1) | 0.043 |
Prolonged MV, n, (%) | 52(13.6) | 8(9.4) | 34(13.1) | 10(25.6) | 0.046 |
Arrhythmia, n, (%) | 15(4.4) | 4(4.7) | 6(2.3) | 5(12.8) | 0.006 |
Poor prognosis, n, (%) | 80(20.9) | 15(17.6) | 49(18.9) | 16(41.0) | 0.005 |